The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Barker Richard W since 2013.
The trader's CIK number is 1255954.
At the time of the last reporting, Barker Richard W was the Director of Celgene Corp /de/. (stock ticker symbol CELG).
Also see all insider trading activities at Celgene Corp /de/.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | CELG | 0 | $0 | 0 | $0 | 1,125 | $0 |
| 2018 | CELG | 0 | $0 | 0 | $0 | 1,000 | $0 |
| 2017 | CELG | 0 | $0 | 0 | $0 | 734 | $0 |
| 2016 | CELG | 0 | $0 | 20,000 | $2,216,400 | 22,801 | $738,400 |
| 2015 | CELG | 0 | $0 | 0 | $0 | 4,867 | $0 |
| 2014 | CELG | 0 | $0 | 17,600 | $1,531,657 | 20,666 | $591,387 |
| 2013 | CELG | 0 | $0 | 0 | $0 | 1,033 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-06-15 | CELG | Option Ex | 1,125 | .00 | 0 |
| 2018-06-17 | CELG | Option Ex | 1,000 | .00 | 0 |
| 2017-07-01 | CELG | Option Ex | 734 | .00 | 0 |
| 2016-09-23 | CELG | Option Ex | 20,000 | 36.92 | 738,400 |
| 2016-09-23 | CELG | Sale | 20,000 | 110.82 | 2,216,400 |
| 2016-07-01 | CELG | Option Ex | 733 | .00 | 0 |
| 2016-06-12 | CELG | Option Ex | 2,068 | .00 | 0 |
| 2015-07-01 | CELG | Option Ex | 733 | .00 | 0 |
| 2015-06-12 | CELG | Option Ex | 2,066 | .00 | 0 |
| 2015-06-13 | CELG | Option Ex | 2,068 | .00 | 0 |
| 2014-07-25 | CELG | Option Ex | 18,600 | 31.80 | 591,387 |
| 2014-07-25 | CELG | Sale | 17,600 | 87.03 | 1,531,657 |
| 2014-06-13 | CELG | Option Ex | 1,033 | .00 | 0 |
| 2014-06-12 | CELG | Option Ex | 1,033 | .00 | 0 |
| 2013-06-13 | CELG | Option Ex | 1,033 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Barker Richard W (Director of Celgene Corp /de/ at the time of this reporting) see the Securities and Exchange Commission (SEC) website.